Exact Sciences Corp (NASDAQ: EXAS) kicked off on Tuesday, up 2.02% from the previous trading day, before settling in for the closing price of $52.48. Over the past 52 weeks, EXAS has traded in a range of $39.97-$72.83.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -54.24%. While this was happening, its average annual earnings per share was recorded 90.85%. With a float of $185.74 million, this company’s outstanding shares have now reached $188.59 million.
Let’s determine the extent of company efficiency that accounts for 7000 employees. In terms of profitability, gross margin is 68.19%, operating margin of -36.55%, and the pretax margin is -36.39%.
Exact Sciences Corp (EXAS) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Diagnostics & Research Industry. The insider ownership of Exact Sciences Corp is 1.53%, while institutional ownership is 97.52%. The most recent insider transaction that took place on Jun 13 ’25, was worth 170,612. In this transaction Director of this company sold 3,207 shares at a rate of $53.20, taking the stock ownership to the 72,759 shares. Before that another transaction happened on Jun 13 ’25, when Company’s Director proposed sale 3,207 for $53.20, making the entire transaction worth $170,612.
Exact Sciences Corp (EXAS) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 90.85% per share during the next fiscal year.
Exact Sciences Corp (NASDAQ: EXAS) Trading Performance Indicators
Take a look at Exact Sciences Corp’s (EXAS) current performance indicators. Last quarter, stock had a quick ratio of 2.38. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.57. Likewise, its price to free cash flow for the trailing twelve months is 52.02.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.50, a number that is poised to hit -0.13 in the next quarter and is forecasted to reach 0.37 in one year’s time.
Technical Analysis of Exact Sciences Corp (EXAS)
Looking closely at Exact Sciences Corp (NASDAQ: EXAS), its last 5-days average volume was 2.27 million, which is a drop from its year-to-date volume of 2.65 million. As of the previous 9 days, the stock’s Stochastic %D was 41.54%.
During the past 100 days, Exact Sciences Corp’s (EXAS) raw stochastic average was set at 72.53%, which indicates a significant increase from 47.20% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 2.07 in the past 14 days, which was lower than the 2.16 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $53.53, while its 200-day Moving Average is $55.29. However, in the short run, Exact Sciences Corp’s stock first resistance to watch stands at $54.08. Second resistance stands at $54.62. The third major resistance level sits at $55.66. If the price goes on to break the first support level at $52.50, it is likely to go to the next support level at $51.46. Should the price break the second support level, the third support level stands at $50.92.
Exact Sciences Corp (NASDAQ: EXAS) Key Stats
The company with the Market Capitalisation of 10.10 billion has total of 188,638K Shares Outstanding. Its annual sales at the moment are 2,759 M in contrast with the sum of -1,029 M annual income. Company’s last quarter sales were recorded 706,790 K and last quarter income was -101,220 K.
